{"id":"chewable-tablet","safety":{"commonSideEffects":[{"rate":null,"effect":"Dental caries"},{"rate":null,"effect":"Gastrointestinal upset"}]},"_chembl":{"chemblId":"CHEMBL635","moleculeType":"Small molecule","molecularWeight":"358.43"},"_dailymed":{"setId":"48b0eb83-861d-4222-8853-16a2bcf7844f","title":"MARBOFLOXACIN (MARBOFLOXACIN CHEWABLE TABLETS) TABLET, CHEWABLE [BUTLER ANIMAL HEALTH SUPPLY, LLC DBA COVETRUS NORTH AMERICA]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action of the medication within the chewable tablet is dependent on the specific active ingredient, but the tablet itself serves as a delivery system to ensure the medication is effectively absorbed by the body.","oneSentence":"Chewable tablets are designed to facilitate the administration of medication in a convenient and easy-to-swallow form.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T05:59:20.699Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Oral health maintenance"}]},"trialDetails":[{"nctId":"NCT05757050","phase":"NA","title":"Mental Balance Study","status":"COMPLETED","sponsor":"A. Vogel AG","startDate":"2023-03-09","conditions":"Mental Health Wellness 1, Work Related Stress","enrollment":36},{"nctId":"NCT07424495","phase":"","title":"Chewable Tablets Produced by Three-Dimensional Printing: A Sensory Acceptability Study in Children and Adolescents","status":"NOT_YET_RECRUITING","sponsor":"University of Brasilia","startDate":"2027-03","conditions":"Palatability Assessment of 3D-printed Chewable Tablets in Children and Adolescents","enrollment":100},{"nctId":"NCT06141083","phase":"NA","title":"Effect of TCI188 Probiotic on Oral Health","status":"COMPLETED","sponsor":"TCI Co., Ltd.","startDate":"2023-11-01","conditions":"Periodontal Diseases","enrollment":55},{"nctId":"NCT07388121","phase":"NA","title":"The Effect of Vitamin C Supplementation on Gut Microbiota Composition and Function in Healthy Adults","status":"RECRUITING","sponsor":"University of Glasgow","startDate":"2025-11-01","conditions":"Short Chain Fatty Acids Concentration in Stools, Gut Microbiota Diversity and Composition","enrollment":23},{"nctId":"NCT07384130","phase":"NA","title":"Oral Probiotics for Halitosis in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"John Hale","startDate":"2026-03-15","conditions":"Halitosis","enrollment":40},{"nctId":"NCT03650400","phase":"PHASE2","title":"Pharmacokinetics, Safety and Tolerability of Fevipiprant Delivered Via a Once Daily Chewable Tablet in Children Aged 6 to < 12 Years With Asthma","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2019-05-01","conditions":"Asthma","enrollment":11},{"nctId":"NCT07291700","phase":"","title":"Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy","status":"RECRUITING","sponsor":"Bayer","startDate":"2025-11-18","conditions":"Gastroesophageal Reflux","enrollment":167},{"nctId":"NCT07231185","phase":"PHASE2","title":"Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"Aspargo Labs, Inc","startDate":"2026-01","conditions":"Erectile Dysfunction","enrollment":200},{"nctId":"NCT06019728","phase":"PHASE4","title":"A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme","status":"COMPLETED","sponsor":"Sanofi","startDate":"2023-11-10","conditions":"Fabry's Disease","enrollment":8},{"nctId":"NCT03270839","phase":"PHASE4","title":"Motion Sickness Medications and Vestibular Time Constant","status":"COMPLETED","sponsor":"Medical Corps, Israel Defense Force","startDate":"2017-06-01","conditions":"Drug Reaction","enrollment":54},{"nctId":"NCT06752330","phase":"NA","title":"Evaluation of the Effect of a Probiotic in Patients Undergoing Orthodontic Therapy","status":"COMPLETED","sponsor":"University of Turin, Italy","startDate":"2025-01-01","conditions":"Orthodontics, Dental Hygiene, Gingivitis and Periodontal Diseases","enrollment":60},{"nctId":"NCT06128447","phase":"PHASE3","title":"Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH)","status":"RECRUITING","sponsor":"Zero Point Five Therapeutics","startDate":"2025-02-14","conditions":"Soil-Transmitted Helminthiasis (STH)","enrollment":300},{"nctId":"NCT06071442","phase":"PHASE1","title":"Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine","status":"COMPLETED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2024-01-17","conditions":"Healthy Participants","enrollment":60},{"nctId":"NCT06974747","phase":"NA","title":"Immunomodulatory Effect of Pleuran in Children With Recurrent Respiratory Tract Infections","status":"COMPLETED","sponsor":"Pleuran, s.r.o.","startDate":"2023-09-25","conditions":"Respiratory Tract Infection","enrollment":217},{"nctId":"NCT01869491","phase":"PHASE3","title":"Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study","status":"COMPLETED","sponsor":"Reckitt Benckiser Healthcare (UK) Limited","startDate":"2013-06-05","conditions":"Gastroesophageal Reflux Disease, Dyspepsia","enrollment":1107},{"nctId":"NCT01872897","phase":"PHASE3","title":"Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients","status":"COMPLETED","sponsor":"Reckitt Benckiser Healthcare (UK) Limited","startDate":"2013-07-02","conditions":"Gastroesophageal Reflux Disease","enrollment":45},{"nctId":"NCT06169826","phase":"PHASE4","title":"Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2025-04","conditions":"Alzheimer Disease","enrollment":""},{"nctId":"NCT06655194","phase":"PHASE1","title":"A Study to Learn if There is a Difference in the Blood Levels of Acetylsalicylic Acid When Taken as Different Chewable Tablets on an Empty Stomach by Healthy Participants","status":"COMPLETED","sponsor":"Bayer","startDate":"2025-02-26","conditions":"Bioequivalence, Healthy Volunteers, Platelet Aggregation Inhibition","enrollment":38},{"nctId":"NCT06541691","phase":"NA","title":"Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease","status":"RECRUITING","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2024-03-06","conditions":"Atherosclerotic Cardiovascular Disease, Coronary Artery Disease, Ischemic Heart Disease","enrollment":3000},{"nctId":"NCT06836024","phase":"PHASE2, PHASE3","title":"A Trial of Actazin Versus PEG 3350 for Maintenance Therapy in Children With Constipation","status":"NOT_YET_RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2025-06-01","conditions":"Constipation - Functional, Constipation, Constipation Aggravated","enrollment":60},{"nctId":"NCT03792763","phase":"PHASE2","title":"Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients","status":"COMPLETED","sponsor":"Arbeitsgemeinschaft medikamentoese Tumortherapie","startDate":"2019-09-30","conditions":"Multiple Myeloma","enrollment":8},{"nctId":"NCT04485039","phase":"PHASE4","title":"Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders","status":"COMPLETED","sponsor":"SIGA Technologies","startDate":"2022-06-08","conditions":"Smallpox","enrollment":44},{"nctId":"NCT06661018","phase":"NA","title":"Effect Supplementation of COenzyme Q10 in Acute STEMI Underwent PPCI","status":"COMPLETED","sponsor":"Universitas Diponegoro","startDate":"2024-01-28","conditions":"ST Segment Elevation Myocardial Infarction (STEMI), Coenzyme Q10","enrollment":46},{"nctId":"NCT06466473","phase":"PHASE1","title":"A Study to Learn How Different Forms of The Study Medicine Called Phenytoin Are Taken up Into the Blood in Healthy Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2024-07-03","conditions":"Healthy","enrollment":35},{"nctId":"NCT00836901","phase":"PHASE1","title":"Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Non-Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2003-09","conditions":"Healthy","enrollment":52},{"nctId":"NCT00835705","phase":"PHASE1","title":"Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2003-09","conditions":"Healthy","enrollment":52},{"nctId":"NCT00838279","phase":"PHASE1","title":"Lamotrigine 25 mg Chewable Tablets, Fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-02","conditions":"Healthy","enrollment":32},{"nctId":"NCT00838136","phase":"PHASE1","title":"Lamotrigine 25 mg Chewable Tablets, Non-Fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-02","conditions":"Healthy","enrollment":32},{"nctId":"NCT06268964","phase":"PHASE1, PHASE2","title":"Exploring Treatments for Children's Abdominal Pain: Comparing Trimebutine and Probiotics","status":"RECRUITING","sponsor":"Universidad de Colima","startDate":"2024-09-01","conditions":"Functional Abdominal Pain Syndrome, Functional Gastrointestinal Disorders, Irritable Bowel Syndrome Variant of Childhood","enrollment":82},{"nctId":"NCT00700661","phase":"PHASE3","title":"A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-01","conditions":"Asthma","enrollment":500},{"nctId":"NCT00092092","phase":"PHASE4","title":"Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-10","conditions":"Asthma, Bronchial","enrollment":71},{"nctId":"NCT06552624","phase":"NA","title":"Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers","status":"COMPLETED","sponsor":"Valenta Pharm JSC","startDate":"2021-07-07","conditions":"Heartburn, Acid-dependent Diseases of the Gastrointestinal Tract, Symptomatic Treatment of Gastric and Duodenal Ulcers","enrollment":40},{"nctId":"NCT04999098","phase":"PHASE4","title":"Echinaforce COVID-19 Shedding Study","status":"TERMINATED","sponsor":"A. Vogel AG","startDate":"2021-11-15","conditions":"COVID-19 Respiratory Infection, SARS-CoV2 Infection","enrollment":40},{"nctId":"NCT06098742","phase":"NA","title":"Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers","status":"RECRUITING","sponsor":"Valenta Pharm JSC","startDate":"2024-04-25","conditions":"Heartburn, Acid-dependent Diseases of the Gastrointestinal Tract, Symptomatic Treatment of Gastric and Duodenal Ulcers","enrollment":50},{"nctId":"NCT06375694","phase":"NA","title":"Probiotic Effect on Dietary Nitrate to Plasma Nitrite Production ( OPEDNPN )","status":"RECRUITING","sponsor":"Wake Forest University","startDate":"2024-06-01","conditions":"Hypertension, Cardiovascular Diseases, Diabetes","enrollment":20},{"nctId":"NCT06464718","phase":"NA","title":"Effectiveness of Calcium and Vitamin D, With and Without Collagen Peptide, in Enhancing Bone Mineral Density on Postmenopausal Women With Osteopenia","status":"COMPLETED","sponsor":"Frontier Medical and Dental College, Abbotabad","startDate":"2022-06-20","conditions":"Osteopenia","enrollment":30},{"nctId":"NCT01852812","phase":"PHASE3","title":"Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-06-07","conditions":"Perennial Allergic Rhinitis","enrollment":87},{"nctId":"NCT01857063","phase":"PHASE3","title":"Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-06-10","conditions":"Seasonal Allergic Rhinitis","enrollment":220},{"nctId":"NCT04762082","phase":"PHASE1","title":"A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Seattle Gummy Company","startDate":"2025-05-01","conditions":"Erectile Dysfunction","enrollment":30},{"nctId":"NCT06435481","phase":"PHASE4","title":"Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics","status":"NOT_YET_RECRUITING","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2024-09","conditions":"Adrenal Insufficiency","enrollment":35},{"nctId":"NCT00442559","phase":"PHASE4","title":"Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-01","conditions":"Asthma, Allergic Rhinitis","enrollment":191},{"nctId":"NCT00534976","phase":"PHASE4","title":"The Effect of Montelukast on Difficulty in Breathing After Exercise in Pediatric Patients (MK0476-377)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-02","conditions":"Exercise-induced Bronchoconstriction (EIB)","enrollment":364},{"nctId":"NCT00127166","phase":"PHASE3","title":"Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-12","conditions":"Exercise Induced Asthma","enrollment":154},{"nctId":"NCT05625334","phase":"PHASE1","title":"Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Healthy Adults.","status":"COMPLETED","sponsor":"Vectura, Inc.","startDate":"2022-10-14","conditions":"Healthy Volunteers","enrollment":86},{"nctId":"NCT05625347","phase":"PHASE1","title":"Study to Compare the Pharmacokinetics and Pharmacodynamics of ASA Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Adult Subjects With Obstructive or Restrictive Pulmonary Function","status":"TERMINATED","sponsor":"Vectura, Inc.","startDate":"2023-03-11","conditions":"Obstructive Pulmonary Function, Restrictive Pulmonary Function","enrollment":4},{"nctId":"NCT04286178","phase":"NA","title":"Exercise, Creatine and Coenzyme Q10 for Childhood Myositis","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2021-04-06","conditions":"Myositis, Juvenile","enrollment":15},{"nctId":"NCT06279429","phase":"NA","title":"Sucrosomial Iron on Insomnia in Non-dialysis Chronic Kidney Disease Patients With Iron Deficiency Anemia","status":"UNKNOWN","sponsor":"Kuang Tien General Hospital","startDate":"2022-05-31","conditions":"CKD, Sleep Disorder","enrollment":100},{"nctId":"NCT02889809","phase":"PHASE4","title":"Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-07-10","conditions":"Asthma","enrollment":477},{"nctId":"NCT04588727","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-10-15","conditions":"Cardiovascular Disease","enrollment":103},{"nctId":"NCT05110599","phase":"PHASE2","title":"Bryophyllum Pinnatum Treatment of Anxiety Related to Signs of Preterm Birth","status":"TERMINATED","sponsor":"Christian Haslinger","startDate":"2022-07-12","conditions":"Preterm Labor, Anxiety","enrollment":60},{"nctId":"NCT04351698","phase":"PHASE2, PHASE3","title":"SMILES: Study of Montelukast in Sickle Cell Disease","status":"UNKNOWN","sponsor":"Great Ormond Street Hospital for Children NHS Foundation Trust","startDate":"2023-10-16","conditions":"Anemia, Sickle Cell, Sleep-Disordered Breathing","enrollment":200},{"nctId":"NCT04472065","phase":"NA","title":"Study of Probiotic Use After Childbirth in Relation to Emotional Well-Being","status":"COMPLETED","sponsor":"Elizabeth Austen Lawson","startDate":"2021-03-10","conditions":"Mental Health Wellness","enrollment":46},{"nctId":"NCT02338687","phase":"PHASE4","title":"Low Dose Calcium to Prevent Preeclampsia","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2014-10","conditions":"Pre-Eclampsia, Hypertension, Pregnancy-Induced, Dietary Calcium Deficiency","enrollment":1040},{"nctId":"NCT00754208","phase":"PHASE4","title":"Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2008-09-18","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":7},{"nctId":"NCT06042985","phase":"PHASE4","title":"Comparison of the Absorption of Calcium Citrate and Calcium Carbonate in Patients With an RYGB, LSG, and OAGB","status":"UNKNOWN","sponsor":"General Committee of Teaching Hospitals and Institutes, Egypt","startDate":"2023-12-01","conditions":"Calcium Citrate Absorption, Calcium Carbonate Absorption","enrollment":150},{"nctId":"NCT04932265","phase":"PHASE1","title":"Effect of Gamma-cyclodextrin on the Bioavailability of Ginsenosides","status":"SUSPENDED","sponsor":"EuroPharma, Inc.","startDate":"2021-09-01","conditions":"Drug Absorption","enrollment":3},{"nctId":"NCT05810233","phase":"NA","title":"Effect of Vitamin C on Allergy Skin Test","status":"UNKNOWN","sponsor":"National University of Malaysia","startDate":"2023-07-15","conditions":"Rhinitis, Allergic, Allergy","enrollment":90},{"nctId":"NCT04037826","phase":"NA","title":"L. Reuteri DSM 17938 and L. Reuteri ATCC PTA 6475 in Moderate to Severe Irritable Bowel in Adults","status":"COMPLETED","sponsor":"Innovacion y Desarrollo de Estrategias en Salud","startDate":"2018-07-12","conditions":"Irritable Bowel Syndrome","enrollment":140},{"nctId":"NCT05913310","phase":"PHASE4","title":"Efficacy and Safety of Kui-Yuan Chewable Tablets in Patients With Hyperuricemia","status":"UNKNOWN","sponsor":"Quan Jiang","startDate":"2023-07","conditions":"Hyperuricemia","enrollment":126},{"nctId":"NCT05303636","phase":"PHASE4","title":"LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women","status":"RECRUITING","sponsor":"Insud Pharma","startDate":"2022-03-28","conditions":"Change in Bone Mineral Density, Bone Loss","enrollment":1710},{"nctId":"NCT05706259","phase":"NA","title":"A Comparative Dissolution and Absorption Study of an Orodispersible Powder, Chewable Tablet and Soft Gel Capsule Vitamin D3 Supplementation","status":"COMPLETED","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2023-01-11","conditions":"Vitamin D Deficiency","enrollment":40},{"nctId":"NCT05528198","phase":"NA","title":"Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fasted Healthy Volunteers","status":"COMPLETED","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2018-12-28","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT05531994","phase":"NA","title":"Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fed Healthy Volunteers","status":"COMPLETED","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2018-11-27","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT05596383","phase":"NA","title":"Effects of Vitamin D Supplementation on SOD,IL-6 and Insulin Resistance in Type 2 Diabetes Mellitus (DM)","status":"UNKNOWN","sponsor":"Trisakti University","startDate":"2022-02-12","conditions":"Type2 Diabetes Mellitus","enrollment":112},{"nctId":"NCT04075110","phase":"EARLY_PHASE1","title":"Investigation the Safety and Efficacy of The Antileukotriene Agents, Montelukast, as Adjuvant Therapy in Obese Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Sadat City University","startDate":"2019-07-01","conditions":"Obesity; Endocrine; Diabetes Type 2","enrollment":100},{"nctId":"NCT04811339","phase":"PHASE4","title":"Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol)","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2020-10-27","conditions":"Diarrhea, COVID-19","enrollment":60},{"nctId":"NCT05211219","phase":"NA","title":"The Role of Probiotics in Periodontal Disease","status":"COMPLETED","sponsor":"Gazi University","startDate":"2021-01-07","conditions":"Periodontal Diseases","enrollment":36},{"nctId":"NCT05624177","phase":"NA","title":"Colonisation Efficacy of a Probiotic Chewing Gum.","status":"UNKNOWN","sponsor":"BLIS Technologies Limited","startDate":"2022-12","conditions":"Microbial Colonization","enrollment":20},{"nctId":"NCT03416361","phase":"NA","title":"VItamiN D treatIng Chronic heArT Failure (the Effect of Vitamin D Supplementation in Patients With Heart Failure)","status":"NOT_YET_RECRUITING","sponsor":"University of Leeds","startDate":"2023-12-01","conditions":"Chronic Heart Failure","enrollment":1253},{"nctId":"NCT04046263","phase":"PHASE4","title":"Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-02-01","conditions":"Peritoneal Dialysis Complication, Hyperphosphatemia, Hypoalbuminemia","enrollment":17},{"nctId":"NCT02644291","phase":"PHASE1","title":"Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2016-05","conditions":"Medulloblastoma, Astrocytoma, Grade III, Glioblastoma","enrollment":16},{"nctId":"NCT05375396","phase":"NA","title":"Microbial Colonization of Dairy Free Oral Probiotics","status":"UNKNOWN","sponsor":"John Hale","startDate":"2022-06-01","conditions":"Microbial Colonization","enrollment":30},{"nctId":"NCT03069963","phase":"PHASE1","title":"PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-02-24","conditions":"Gastroesophageal Reflux Disease","enrollment":24},{"nctId":"NCT05367518","phase":"NA","title":"Colonisation Efficacy of Oral Probiotic Fast Melt Powder","status":"UNKNOWN","sponsor":"BLIS Technologies Limited","startDate":"2022-05-15","conditions":"Microbial Colonization","enrollment":20},{"nctId":"NCT03065816","phase":"PHASE1","title":"Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-02-09","conditions":"Gastroesophageal Reflux Disease","enrollment":34},{"nctId":"NCT05325489","phase":"PHASE3","title":"Comparison of Nebulized Budesonide and Intranasal Budesonide Spray in Children With Adenotonsillar Hypertrophy","status":"UNKNOWN","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2022-04","conditions":"Snoring, Mouth Breathing","enrollment":100},{"nctId":"NCT04080947","phase":"PHASE1, PHASE2","title":"The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis","status":"COMPLETED","sponsor":"Sadat City University","startDate":"2019-08-01","conditions":"Steatohepatitis, Nonalcoholic","enrollment":56},{"nctId":"NCT05096052","phase":"PHASE3","title":"PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19","status":"UNKNOWN","sponsor":"Bioxytran Inc.","startDate":"2022-04-01","conditions":"COVID-19, COVID-19 Pandemic, COVID-19 Respiratory Infection","enrollment":408},{"nctId":"NCT01615874","phase":"PHASE2","title":"Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2013-01","conditions":"Asthma","enrollment":""},{"nctId":"NCT00540839","phase":"PHASE3","title":"A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2007-11","conditions":"Asthma, Bronchial","enrollment":""},{"nctId":"NCT00780403","phase":"PHASE4","title":"Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-08","conditions":"Allergies","enrollment":220},{"nctId":"NCT00779116","phase":"PHASE4","title":"Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-09","conditions":"Allergies","enrollment":217},{"nctId":"NCT00968149","phase":"PHASE3","title":"A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-03","conditions":"Seasonal Allergic Rhinitis","enrollment":413},{"nctId":"NCT00968201","phase":"PHASE3","title":"Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1997-12","conditions":"Asthma","enrollment":689},{"nctId":"NCT00461032","phase":"PHASE3","title":"Montelukast Back to School Asthma Study (0476-340)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06","conditions":"Asthma","enrollment":1162},{"nctId":"NCT00289874","phase":"PHASE3","title":"Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-03","conditions":"Asthma","enrollment":421},{"nctId":"NCT04526821","phase":"PHASE2","title":"Lactoferrin for Prevention of COVID-19 in Health Care Workers","status":"TERMINATED","sponsor":"Universidad Peruana Cayetano Heredia","startDate":"2020-10-17","conditions":"SARS-CoV-2","enrollment":209},{"nctId":"NCT03772158","phase":"PHASE1","title":"Cetirizine Chewable Bioequivalence and Food Effect Study","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division","startDate":"2018-12-11","conditions":"Allergy","enrollment":40},{"nctId":"NCT05109390","phase":"PHASE1","title":"A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults","status":"COMPLETED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2018-07-27","conditions":"Healthy","enrollment":72},{"nctId":"NCT01751568","phase":"PHASE1, PHASE2","title":"Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2014-11-12","conditions":"HIV Infections, Tuberculosis","enrollment":40},{"nctId":"NCT00485264","phase":"PHASE1, PHASE2","title":"Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2007-09-17","conditions":"HIV Infections","enrollment":153},{"nctId":"NCT00312091","phase":"PHASE1, PHASE2","title":"Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-12","conditions":"HIV Infections","enrollment":44},{"nctId":"NCT05002179","phase":"PHASE4","title":"Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections","status":"COMPLETED","sponsor":"A. Vogel AG","startDate":"2020-11-20","conditions":"Respiratory Tract Infections, Common Cold","enrollment":122},{"nctId":"NCT03993288","phase":"PHASE3","title":"Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia.","status":"COMPLETED","sponsor":"Sandoz","startDate":"2019-06-27","conditions":"Mild and Moderate Iron-deficiency Anaemia","enrollment":267},{"nctId":"NCT02004288","phase":"NA","title":"The Role of Lactobacillus Reuteri in Children and Adolescents With Anorexia Nervosa","status":"COMPLETED","sponsor":"BioGaia AB","startDate":"2013-12","conditions":"Anorexia Nervosa, Constipation","enrollment":31},{"nctId":"NCT04753619","phase":"PHASE2","title":"Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management","status":"UNKNOWN","sponsor":"University of Baghdad","startDate":"2021-01-03","conditions":"Covid-19, SARS Pneumonia","enrollment":150},{"nctId":"NCT00441545","phase":"PHASE3","title":"Head to Head Study Against Sevelamer Hydrochloride","status":"COMPLETED","sponsor":"Shire","startDate":"2007-01-05","conditions":"Chronic Kidney Disease, Stage 5","enrollment":182},{"nctId":"NCT00880750","phase":"PHASE1","title":"Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults","status":"COMPLETED","sponsor":"Shire","startDate":"2009-01-28","conditions":"End Stage Renal Disease","enrollment":72},{"nctId":"NCT01128179","phase":"PHASE2","title":"Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD","status":"COMPLETED","sponsor":"Shire","startDate":"2010-12-06","conditions":"Chronic Kidney Disease","enrollment":35},{"nctId":"NCT03644264","phase":"PHASE3","title":"PA21 Safety and Efficacy in Adult Chinese Subjects","status":"COMPLETED","sponsor":"Vifor Fresenius Medical Care Renal Pharma","startDate":"2018-08-31","conditions":"Chronic Kidney Disease Requiring Chronic Dialysis, Hyperphosphatemia","enrollment":286}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":185,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Chewable Tablet","genericName":"Chewable Tablet","companyName":"Frontier Medical and Dental College, Abbotabad","companyId":"frontier-medical-and-dental-college-abbotabad","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Chewable tablets are designed to facilitate the administration of medication in a convenient and easy-to-swallow form. Used for Oral health maintenance.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}